NovoCure Limited
Key Metrics
Market Snapshot
About
NovoCure Limited is a global oncology company developing Tumor Treating Fields (TTFields) therapy, a novel cancer treatment that uses electric fields to disrupt cell division in tumors. The flagship product Optune is FDA-approved for glioblastoma and mesothelioma. NovoCure is conducting clinical trials across multiple solid tumor types including brain, lung, ovarian, and pancreatic cancers.